| http://www.w3.org/ns/prov#value | - According to two different reviews on the ALS market completed earlier this year (NeuroPerspective and The Pink Sheet), there are nearly 40 other smaller biotechnology companies with products either being directly or co-developed as potential treatments for ALS. R&D activities on ALS are conducted on every continent except Antarctica.
|
